Dissolution Testing of Immediate Release Solid Oral Dosage Forms
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 25, 1997
October 17, 2019
8cc84e15-f9e6-4319-afe6-f59a882e535c
Related Documents
SUPAC-SS: Nonsterile Semisolid Dosage Forms; Scale-Up and Post-Approval Changes: Chemistry, Manufacturing and Controls; In Vitro Release Testing and In Vivo Bioequivalence Documentation: Guidance for Industry
Guidance DocumentMay 1, 1997Center for Drug Evaluation and Research
SUPAC-MR: Modified Release Solid Oral Dosage Forms Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation: Guidance for Industry
Guidance DocumentOctober 6, 1997Center for Drug Evaluation and Research
Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations
Guidance DocumentSeptember 1, 1997Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.